Clozapine-induced acetylcholine release in the rat prefrontal cortex, nucleus accumbens and striatum does not develop tolerance

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 8, 1998, Pages 1379-1397

  Parada, Marco A ^a,b   De Parada, Marina Puig ^a   Hernandez, Luis ^a   García, Francisco ^a   Murzi, Euro ^a   Contreras, Quilianio ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b NONE   (Venezuela)

Author keywords

Antipsychotic drugs; Atypical neuroleptics; Multiple brain microdialysis; Neurochemical sensitization; Tolerance

Indexed keywords

ACETYLCHOLINE; CLOZAPINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CORPUS STRIATUM; DRUG TOLERANCE; ELECTROCHEMICAL DETECTION; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0032213093     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(98)00076-1     Document Type: Article

References (55)

1. BARNES, D.E., ROBINSON, B., CSERNANSKY, J.G. and BELLOWS, E.P. (1990) Sensitization vs. tolerance to haloperidol-induced catalepsy: Multiple determinants. Pharmacol. BIOCHEM. Behav. 36: 883-887.
2. BOLDEN, C., CUSACK, B. and RICHELSON, E. (1991) Antagonism by antimuscarinic and neuroleptic compounds at five cloned human muscarinic cholinergic receptors expressed in chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 260: 576-580.
3. BOURDELAIS, A.J. and DEUTCH, A.Y. (1994) The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. Cereb. Cortex 4: 69-77.
4. BRUNELLO, N., MASOTTO, C., STEARDO, L., MARKSTEIN R. and RACAGNI, G. (1995) New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13:177-213.
5. CAREY, R.J. and DEVEAUGH-GEISS, J. (1984) Treatment schedule as a determinant of the development of tolerance to haloperidol. Psychopharmacology (Berlin) 82: 164-167.
6. CHIODO, L.A. and BUNNEY, B. S. (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3: 1607-1619.
7. COMPTON, D.R. and KENNETH, M.J. (1989) Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 248: 521-530.
8. CREESE, I., BURT, D.R. and SNYDER, S.H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antipsychotic drugs. Science 192: 481-483.
9. CSERNANSKY, J.G., BELLOWS, E.P., BARNES, D.E. and LOMBROZO, L. (1990) Sensitization vs. tolerance to the dopamine turnover-elevating effects of haloperidol: The effect of regular/intermitent dosing. Psychopharmacology (Berlin) 101: 519-524.
10. DAVIS, J.M., BARTER, J.T. and KANE, J.M. (1989) Antipsychotic drugs. In: Comprehensive Textbook of Psychiatry. H.I. Kaplan and B.J. Sadock (Eds.), Vol. 2, tomo I, pp 1591-1626, Williams and Wilkins, Baltimore.
11. DYER, R.J., MURUGAIAH, K., THEODOROU, A., CLOW, A., JENNER, P. and MARSDEN, C.D. (1981) During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated. Life Sci. 28: 215-229.
12. GEORGIEVA, J. LUTHMAN, J., MOHRINGE, B. and MAGNUSSON O. (1993) Tissue and microdialysate changes after repeated and permanent probe implantation in the striatum of freely moving rats. Brain Res. Bull. 31: 463-470.
13. GERLACH, J. and SIMMELSGARD, H. (1978) Tardive dyskinesia during and folowing treatment with haloperidol, haloperidol and biperiden, thioridazine and clozapine. Psychopharmacology 59: 105-112.
14. GUNNET, J. W. and MOORE, K.E. (1988) Neuroleptics and neuroendocrine function. Ann. Rev. Pharmacol. Toxicol. 28: 347-366.
15. HERMAN, E. and PLEASURE, H. (1963) Clinical evaluation of thioridazine and chlorpromazine in chronic schizophrenia. Diseases Nervous System 24: 54-59.
16. HERNANDEZ, L. and HOEBEL, B.G. (1989) Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Brain Res. Bull. 22: 763-769.
17. HERNANDEZ, L. and HOEBEL, B.G. (1995) Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats. Pharmacol. Biochem. Behav. 52: 581-589.
18. HERNANDEZ, L., STANLEY, B.G. and HOEBEL, B.G. (1986) A small, removable microdialysis probe. Life Sci. 39: 2629-2637.
19. HIETALA, J., KOULU, M., KUOPPAMÄKI, M., LAPPALAINEN, J. and SYVÄLAHTI, E. (1992) Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brain. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 16: 717-732.
20. JACKSON, D.M., MOHELL, N., ANNELI BENGTSSON and MALMBERG, Å. (1993) What are atypical neuroleptics and how do they work? In: New Generation of Antipsychotic Drugs: Novel Mechanisms of Action. N. Brunello, J. Mendlewicz and G. Racagni (Eds.), pp. 27-38, Int. Acad. Biomed. Drug Res., Basel.
21. KANE, J., HONIGFELD, G., SINGER, J. and MELTZER, H. (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison versus chlorpromazine/benztropine. Arch. Gen. Psychiatry 45: 789-796.
22. KATO, N., SHAH, K.R., FRIESEN, H.G. and HAVLICEK, V. (1981) Effects of chronic treatment with haloperidol on serum prolactin, striatal opiate receptors and ß-endorphin content in the rat brain and pituitary. Prog. Neuro-psychopharmacol. 5: 549-552.
23. LAHTI, R.A., EVANS, D.L., STRATMAN, N.C. and FIGUR, L.M. (1993) Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. Eur. J. Pharmacol. 236: 483-486.
24. LANE, R.F., BLAHA, C.D. and RIVET, J.M. (1988) Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of al noradrenergic receptors demonstrated by in vivo voltammetry. Brain Res. 460: 398-401.
25. LIDSKY, T.I., YABLONSKY-ALTER, E., ZUCK, L. and BANERJEE, S.P. (1993) Anti-glutamatergic effects of clozapine. Neurosci. Lett. 163: 155-158.
26. LJUNGBERG, T. and UNGERSTEDT, U. (1985) A rapid and simple behavioral screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs. Pharmacol. Biochem. Behav. 23: 479-485.
27. MEIL, W. and SEE, R.E. (1994) Single preexposure to fluphenazine produces persisting behavioral sensitization accompanied by tolerance to fluphenazine-induced striatal dopamine overflow in rats. Pharmacol. Biochem. Behav. 48: 605-612.
28. MELTZER, H.Y., BASTANI, B., YOUNG KWON, K., RAMIREZ, L.F., BURNETT, S. and SHARPE, J. (1989) A prospective study of clozapine in treatment-resistant schizophrenic patients. Psychopharmacology 99: S68-S72.
29. MELTZER, H.Y., MAES, M. and LEE, M.A. (1993) The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine. Psychopharmacology 112: S95-S104.
30. MOGHADDAM, B. and BUNNEY, B.S. (1990) Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry 14: S51-S57.
31. MOORE, S. and KENYON, P. (1994) Atypical antipsychotics, clozapine and sulpiride do not antagonize amphetamine-induced stereotyped locomotion. Psychopharmacology 114: 123-130.
32. NABER, D., HOLZBACH, K., PERRO, C. and HIPPIUS, H. (1992) Clinical management of clozapine patients in relation to efficacy and side effects. Br. J. Psychiatry 17: 54-59.
33. PARADA, M.A., HERNANDEZ, L., PUIG DE PARADA, M., RADA, P. and MURZI, E. (1997) Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum. J. Pharmacol. Exp. Ther. 281: 582-588.
34. PARADA, M.A., PUIG DE PARADA, M., HERNANDEZ, L., MURZI, E. and GARCIA, F. A practical method for simultaneous multiple intracerebral implantation for microdialysis in rats. Brain Res. Protoc. 2: 141-148.
35. PARADA, M.A., PUIG DE PARADA, M. and HOEBEL, B.G. (1994) A new triple channel swivel for fluid delivery in the range of intracraneal (10 nl) and intravenous (100 μl) self-administration volumes and also suitable for microdialysis. J. Neurosci. Meth. 54: 1-8.
36. PEHEK, E.A. and YAMAMOTO, B.K. (1994) Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J. Neurochem. 63: 2118-2124.
37. PUIG DE PARADA, M., PARADA, M.A., POTHOS, E. and HOEBEL, B.G. (1995) d-Fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin. Life Sci. 56: PL 415-420.
38. RADA, P., MARK, G.P. and HOEBEL, B.G. (1993) In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. Inhibition by serotonin. Brain Res. 619: 98-104.
39. ROBERTSON, G. S. and FIBIGER, H.C. (1992) Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine. Neuroscience 46: 315-328.
40. ROBINSON, T.E. and CAMP, D.M. (1991) The feasibility of repeated intracerebral microdialysis. In: Monitoring Molecules in Neuroscience. H. Rollema, B. Westerink, W.J. Dryfout (Eds.), pp 51-55. University Centre for Pharmacy, Gronengen.
41. ROTH, B.L., CIARANELLO, R.D. and MELTZER, H.Y. (1992) Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1c receptors. J. Pharmacol. Exp. Ther. 260: 1361-1378.
42. SCHWARTZ, J.-C., GIROS, B., MART□RES, M.-P. and SOKOLOFF, P. (1993) Multiple dopamine receptors as molecular targets for antipsychotics. In: New Generation of Antipsychotic Drugs: Novel Mechanisms of Action, N. Brunello, J. Mendlewicz and G. Racagni (Eds.), pp. 1-14. Int. Acad. Biomed. Drug Res., Basel.
43. SEEMAN, P. (1992a) Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7: 261-284.
44. SEEMAN, P. (1992b) Receptor selectivities of atypical neuroleptics. In: Novel antipsychotic drugs. H.Y. Meltzer (Ed.), pp. 145-154. Raven Press, Ltd., New York.
45. SEEMAN, P., GUAN, H.-C. and VAN TOL, H.H.M. (1993) Dopamine D4 receptors elevated in schizophrenia. Nature 365: 441-445.
46. SEEMAN, P. and LEE, T. (1975) Antipsychotic drugs: direct correlation between clinical potencies and presynaptic actions on dopamine neurons. Science 188; 1217-1219.
47. SNYDER, S. H., BANERJEE, S. P., YAMAMURA, H. I. and GREENBER, D. (1974) Drugs, neurotransmitters and schizophrenia. Science 184: 1243-1253.
48. SNYDER, S. H., CREESE, I. and BURT, D. R. (1975) The brain's dopamine receptor: labeling with (H3)dopamine and (H3)haloperidol. Psychopharmacol. Commun. 1: 663-673.
49. TSCHANZ, J. T. and REBEC, G. V. (1989) Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy. Pharmacol. Biochem. Behav. 31: 519-522.
50. VAN TOL, H. H. M., BUNZOW, J. R., GUAN, H.-C., SUNAHARA, R. K., SEEMAN, P., NIZNIK, H. B. and CIVELLI, O. (1991) Cloning of a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine. Nature 350: 614-619.
51. WHITE F.J. and WANG R.Y. (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054-1057.
52. WILSON, W.H. (1992) Clinical review of clozapine treatment in a state hospital. Hosp. Community Psychiatry 43: 700-703.
53. YAMAMOTO, B. K. and COOPERMAN, M. A. (1994) Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14: 4159-4166.
54. YOUNGREN, K. D., MOGHADDAM, B., BUNNEY, B. S. and ROTH, R. H. (1994) Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment. Neurosci. Lett. 165: 41-44.
55. ZARATE, C.A. JR, TOHEN, M. and BALDESSARINI, R.J. (1995) Clozapine in severe mood disorders. J. Clin. Psychiatry 56: 411-417.